Vanda Pharmaceuticals
VNDA
VNDA
136 hedge funds and large institutions have $556M invested in Vanda Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 53 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
4% less funds holding
Funds holding: 141 → 136 (-5)
13% less repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 53
14% less capital invested
Capital invested by funds: $648M → $556M (-$92.5M)
Holders
136
Holding in Top 10
3
Calls
$721K
Puts
$625K
Top Buyers
| 1 | +$53.8M | |
| 2 | +$32.7M | |
| 3 | +$14.4M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$8.47M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.3M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$11.5M | |
| 3 | -$9.31M | |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$7.81M |
| 5 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$7.35M |